Source-backed guidance on scarring and scar revision for patients exploring treatment options, with provider verification tips and practical planning steps.
Last reviewed: 2026-05-06
11 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Hair transplantation is generally not appropriate for active scarring alopecia—disease activity must be controlled for at least one year before surgical options may be considered.
No hair transplant technique is completely scarless; FUE leaves dot scars while FUT produces a linear scar.
Scar revision requires patience—most scars need 12-18 months to mature before treatment can be optimally effective.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Scarring Hair Loss
When hair loss is accompanied by scarring, the underlying biology differs significantly from more common conditions like pattern baldness. Understanding this distinction is essential for anyone exploring treatment options. Our hair loss resources provide broader context on how scarring differs from other forms of alopecia.
What Makes Scarring Alopecia Different
Primary cicatricial alopecia, commonly called scarring alopecia, represents a group of disorders in which hair follicles become permanently destroyed and replaced by fibrous scar tissue. The key distinction from non-scarring alopecias lies in the irreversibility of the damage—follicles that have been destroyed do not regenerate, meaning hair loss in affected areas is permanent. According to the Canadian Medical Association Journal's clinical review, the treatment goal when managing active disease focuses on halting further hair loss and camouflaging residual bald areas, rather than regrowing hair in destroyed follicles. S1
This matters for treatment planning because the approach differs fundamentally from conditions where follicles remain intact but miniaturized. When inflammation destroys the follicle's structure and replaces it with scar tissue, that follicle cannot be revived through medication or transplantation.
Prevalence and Who Is Affected
Scarring alopecia accounts for approximately 7% of patients seen in specialist hair loss clinics. This relatively low prevalence means that not all hair loss practitioners have extensive experience with these conditions. For patients, this underscores the importance of seeking evaluation from clinicians with specific training in diagnosing and managing cicatricial disorders—particularly when considering any surgical intervention. S1
The conditions can affect anyone, though certain subtypes show demographic patterns. Some forms predominate in women, while others affect both genders equally. The condition can appear at any age, though onset is most common in adulthood.
Treatment Goals for Active Disease
When scarring alopecia is active—meaning inflammation is still causing ongoing follicle destruction—the therapeutic focus centers on stopping progression. The International Society of Hair Restoration Surgery's patient education materials emphasize that treatment aims to preserve remaining hair and prevent new areas of involvement. S2
Anti-inflammatory medications, whether topical, oral, or injectable depending on the specific condition, form the cornerstone of medical management. Response to treatment varies considerably between individuals, and finding the right therapeutic approach may require some trial and adjustment under specialist supervision.
Types of Scarring Alopecia
Dermatologists classify cicatricial alopecias based on the predominant inflammatory cell type found in affected tissue. This classification helps guide treatment approaches, as different subtypes respond to different therapeutic strategies. S1
Lymphocytic Forms
Lymphocytic scarring alopecias include lichen planopilaris, frontal fibrosing alopecia, and pseudopelade of Brocq. In these conditions, lymphocytes—a type of white blood cell—drive the inflammatory attack on hair follicles. Clinical features often include perifollicular redness and scaling around remaining hairs, along with progressive loss of follicular openings in affected areas.
These conditions may respond to anti-inflammatory treatments targeting lymphocyte activity. However, the progressive nature means early intervention is generally more successful than waiting until extensive scarring has occurred.
Neutrophilic and Mixed Forms
Neutrophilic scarring alopecias, such as folliculitis decalvans and dissecting cellulitis of the scalp, involve different inflammatory cells and often present with pustules, crusting, or draining sinuses in addition to hair loss. These conditions typically require different therapeutic approaches, sometimes including antibiotics with anti-inflammatory properties or other targeted interventions.
Central centrifugal cicatricial alopecia represents a mixed form that has received increased attention in recent years. It predominantly affects women of African descent and often begins at the crown of the scalp, spreading centrifugally over time.
Why Hair Transplant May Not Be Appropriate
One of the most important considerations for patients with scarring alopecia is understanding why hair transplantation may not be a viable option—especially during active disease phases.
The fundamental issue involves the scar tissue environment. Transplanted follicles require a healthy blood supply and intact recipient site tissue to survive and thrive. In areas of established scarring, this biological infrastructure may be compromised. Additionally, if the underlying inflammatory process remains active, those new follicles could face the same destructive attack that destroyed the original hair.
The ISHRS patient education materials explicitly address this point: patients with active scarring alopecia are generally not candidates for hair transplantation until their disease has been quiescent for an extended period. Only when inflammation has fully subsided—typically for at least one year—might surgical options be reconsidered, and even then, candidacy depends on multiple factors including scar quality and disease history. S2
This is not a limitation of surgical technique but rather a biological reality. Transplanting into actively inflamed or poorly vascularized tissue would likely yield poor results and potentially worsen the underlying condition.
Understanding Disease Burnout
Scarring alopecia follows a variable natural history. After a period of active inflammation and progressive hair loss, many conditions eventually enter a "burned out" phase where inflammatory activity ceases. During this period, the disease becomes static rather than progressive.
Recognizing Burnout Phase
Signs that a scarring condition may have burned out include the absence of new symptoms such as scalp itching, burning, or visible inflammation. No new areas of hair loss should appear, and previously affected areas should show no progression over time. Clinical examination may reveal smooth, shiny areas devoid of follicular openings—indicating established scarring—but without the perifollicular changes seen during active disease.
Professional evaluation is essential to confirm burnout, as patients may not reliably distinguish true quiescence from slow progression. Dermatologists may use clinical examination alone or, in ambiguous cases, biopsy to assess inflammatory activity at the follicle level.
Timing Considerations for Revision
Once burnout is confirmed, patients interested in scar revision or camouflage must account for scar maturation timelines. The American Society of Plastic Surgeons notes that most scars require 12 to 18 months to fully mature before revision treatments—whether surgical or nonsurgical—can be optimally effective. S4
This waiting period allows the scar to soften, pale, and stabilize. Attempting revision on immature scars may yield suboptimal results and could potentially stimulate additional scarring. Patience during this phase is an investment in better outcomes.
Scar Revision Options
For patients with stable scarring—whether from alopecia burnout, previous procedures, or other causes—several approaches may improve appearance. The appropriate choice depends on scar characteristics, patient goals, and realistic expectations about what revision can achieve.
The FUE Scar Myth
A common misconception is that follicular unit extraction (FUE) is a scarless procedure. This is not accurate. The ISHRS clarifies that FUE leaves tiny circular scars at each extraction site across the donor area. These individual scars are typically small and may be less noticeable than the linear scar from FUT, but they are still present. S3
FUE may be preferable for patients who prefer to wear their hair very short, as the dot-like scars can be less apparent than a linear scar in those hairstyles. However, patients seeking FUE specifically to avoid scarring entirely should understand that this expectation does not match reality.
Nonsurgical Approaches
Several nonsurgical options exist for improving scar appearance. Steroid injections may help flatten and soften raised scars, particularly hypertrophic scars, though response varies depending on individual healing factors and scar characteristics. S4
Laser therapies can address color discrepancies and surface texture in some cases. Silicone-based products, whether sheets or gels, represent a topical option for scar management with varying evidence of effectiveness.
Nanofat injections—an emerging approach involving processing of the patient's own adipose tissue—have shown promise in some scar revision applications. This technique involves harvesting a small amount of fat, processing it, and injecting the concentrated regenerative components into scarred areas.
When Surgical Revision Helps
Surgical scar revision may be appropriate for certain linear scars, particularly those that have widened or become raised. The technique involves excising the existing scar and carefully re-closing the wound to create a finer, less noticeable result. Success depends on scar characteristics, skin tension at the site, and individual healing factors.
Scalp micropigmentation offers a different approach, using tiny pigment deposits to create the appearance of hair follicles in bald or scarred areas. This camouflage technique does not restore actual hair but can visually reduce the contrast between scarred and normal scalp.
Working With Your Care Team
Effective management of scarring conditions requires collaboration with qualified healthcare providers who understand the complexities involved. Our guide to treatment options can help you understand the broader landscape of hair restoration approaches.
Questions to Ask Providers
When consulting with potential providers, ask about their specific experience with scarring alopecia cases—not just general hair restoration. Request documentation of training and outcomes where available. Inquire about their diagnostic approach and how they determine disease activity versus burnout.
Ask what happens if disease reactivates after a procedure, and understand the follow-up plan before committing to any intervention. Providers should be transparent about limitations and realistic about what revision can accomplish.
Red Flags to Avoid
Be cautious of providers who guarantee results, dismiss concerns about active disease, or pressure immediate decisions. Avoid practitioners who suggest transplantation without thorough evaluation of inflammatory status or who cannot explain how they will monitor for disease reactivation.
Legitimate providers welcome informed patients and encourage second opinions when appropriate. For provider verification resources, consult professional society directories and regulatory databases.
Medical Travel Considerations
For patients considering treatment in Istanbul or other medical tourism destinations, additional due diligence is warranted.
Provider Verification
Research provider credentials through professional societies such as the International Society of Hair Restoration Surgery, which maintains member directories with credential verification. Look for evidence of training in dermatology or plastic surgery, as well as specific experience with scarring cases.
Visit facilities in advance when possible, or request virtual tours and detailed documentation of protocols. Confirm that facilities follow infection control standards consistent with international guidelines. Our travel coordination services can assist with logistics planning.
Planning for Follow-Up Care
Medical travelers face unique challenges with follow-up. Arrange for local monitoring by a qualified dermatologist who can assess disease activity and provide ongoing care after you return home. Ensure clear communication between your international provider and local care team.
Consider logistics including how to address complications, manage medications during travel, and coordinate long-term monitoring across borders. The American Society of Plastic Surgeons interview materials emphasize that informed patients who plan for continuity of care tend to have better experiences. S4
Key takeaways
Confirm diagnosis and disease activity status with a dermatologist before pursuing any surgical intervention.
Allow 12-18 months for scar maturation before seeking revision treatments.
Set realistic expectations focused on improvement rather than elimination of scars.
Plan for follow-up care coordination between your travel provider and local clinicians.
Understanding scarring and scar revision is the foundation for informed decision-making. Whether managing active disease or exploring revision options for established scars, patience, proper diagnosis, and qualified provider selection remain essential throughout the journey.
Next Steps
If you're exploring hair restoration options and want personalized guidance, our coordination team can help you understand the process and connect with qualified specialists.
1.Filbrandt R, Rufaut N, Jones L, Sinclair R. “Primary cicatricial alopecia: diagnosis and treatment.” Canadian Medical Association Journal. 2013. Accessed 2026-02-19.https://pmc.ncbi.nlm.nih.gov/articles/PMC3855115/
2.International Society of Hair Restoration Surgery. “Cicatricial Alopecia: 3 Things You Should Know.” 2023. Accessed 2026-02-19.https://ishrs.org/cicatricial-alopecia/
